Over 150 Sites in the Midwest Have Global Med Technologies' Blood Management Systems DENVER, Aug. 20 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , today announced that its Wyndgate Technologies(R) division has signed an agreement to license its transfusion management system SafeTrace Tx(R) to Labette Health (Labette), of southeast Kansas. Labette Health becomes the 156th site in the Midwestern United States to use Wyndgate products. Terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Dennis Yoder, MT(ASCP)MBA, Director of Laboratory Services, commented, "Labette Health evaluated several blood management systems and selected Wyndgate's transfusion management software for several reasons. SafeTrace Tx has the comprehensive safety features, centralized transfusion service and application capabilities we need to manage critical patient history and special transfusion requirements for our hospital. The system will also streamline processes, reduce waste and increase efficiency within our operations. Additionally, we were impressed with Wyndgate's ISBT 128 compliance features which will allow us to seamlessly manage orders and blood product inventory from our primary product provider, The American Red Cross." SafeTrace Tx is uniquely designed to fully support the full scale of transfusion services from enterprise-wide centralized facilities to small, individual hospital laboratories. Advanced functionality in SafeTrace Tx, such as electronic crossmatch, automated patient special needs tracking and antigen/antibody functionality, will assist Labette in matching patients for transfusions. SafeTrace Tx is also used by Labette's primary blood supplier, Central Plains American Red Cross, further reinforcing their choice. William Scott Dustin, Vice President of Sales and Marketing at Wyndgate Technologies, commented, "Labette Health recognized its need for a system designed to enhance patient safety, streamline processes and continue to keep it abreast of changing regulations. Our SafeTrace Tx product is a recognized leader among transfusion management systems and we are proud to add Labette Health to our growing customer base." About Labette Health Located in the heart of Southeast Kansas, Labette Health is an acute, intensive and skilled care hospital situated at the southern edge of Parsons, Kansas. Serving a six-county area since 1961, Labette Health has earned recognition as a respected regional medical center renowned for its comprehensive health care services, including skilled and dedicated employees, state-of-the-art medical technology and equipment, and talented medical staff. About Global Med Technologies, Inc. Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies, Inc., +1-303-238-2000, or investors, Paul Holm of H.L. Lanzet, +1-212-888-4570, Web site: http://www.globalmedtech.com/

Copyright